Former Lilly executive joins IU Precision Health Grand Challenge

Carmel Egan, PhD, a top project management and product development executive at Eli Lilly and Co., has joined the Indiana University School of Medicine as project leader of IU's Precision Health Initiative.

Dr. Egan, vice president, Medicines Development Unit at Lilly, has held a series of leadership positions at Lilly. Prior to her most recent position at Lilly, she served as vice president of special Alzheimer's disease initiatives in Lilly's Biomedicines Business Unit and previously as vice president of LRL Portfolio and Project Management.

She will coordinate activities of the Precision Health Initiative as part of her role as associate dean for research affairs at the school. Dr. Egan also has been named chief operating officer of the Indiana Clinical and Translational Sciences Institute.

The Precision Health Initiative, funded in part by the IU Grand Challenges Initiative, is a $120 million multi-campus effort to incorporate the genetic, developmental, behavioral and environmental factors that contribute to an individual’s health and develop highly targeted therapies that will improve the well-being of both individuals and the community.

Dr. Egan, received her PhD in chemistry from University College Dublin in Ireland prior to joining Lilly. She is married to Gerard Carthy and has two teenage sons Gerard and Kevin.